Concepedia

Thomas R. Fuerst

TR

57

Publications

8.8K

Citations

34

H-Index

1986

Active since

Affiliations

Institute for Bioscience and Biotechnology Research(Current)

University of Maryland, College Park

National Institute of Allergy and Infectious Diseases

Advanced Bioscience Laboratories (United States)

National Institutes of Health

Thomas R. Fuerst is an author at Institute for Bioscience and Biotechnology Research specializing in medicine, immunology, and virology.

ORCID

Top concepts

Publications per year

1986–2024

57

Publications

57

Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase.

Thomas R. Fuerst, Edward G. Niles, F. William Studier et al. · Proceedings of the National Academy of Sciences · 1986 · 2.1K citations · Full text

, , +15

New use of BCG for recombinant vaccines

C. Kendall Stover, Vidal F. de la Cruz, Thomas R. Fuerst et al. · Nature · 1991 · 1.5K citations · Full text

, , +5

New mammalian expression vectors

Bernard Moss, Orna Elroy‐Stein, Takuo Mizukami et al. · Nature · 1990 · 524 citations

, , +4

Use of a hybrid vaccinia virus-T7 RNA polymerase system for expression of target genes.

Thomas R. Fuerst, Patricia L. Earl, Bernard Moss · Molecular and Cellular Biology · 1987 · 411 citations · Full text

, , +13

Cap-independent translation of mRNA conferred by encephalomyocarditis virus 5' sequence improves the performance of the vaccinia virus/bacteriophage T7 hybrid expression system.

Orna Elroy‐Stein, Thomas R. Fuerst, Bernard Moss · Proceedings of the National Academy of Sciences · 1989 · 404 citations · Full text

, , +13

Rows per page

1–5 of 57